Accelerate Diagnostics Company Profile (NASDAQ:AXDX)

About Accelerate Diagnostics

Accelerate Diagnostics logoAccelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that improve patient outcomes and lower healthcare costs through the diagnosis of serious infections. The Company's technology platform is built to address these challenges by delivering testing of infectious pathogens in various patient sample types. The Company is focused on the development of a rapid diagnostic platform, the Accelerate ID/AST System (ID/AST System or Accelerate ID/AST System), intended for the diagnosis of infectious pathogens. The ID/AST System utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The ID/AST System features walk-away automation and consists of a fixed instrument and single-use test kit.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AXDX
  • CUSIP:
Key Metrics:
  • Previous Close: $24.75
  • 50 Day Moving Average: $22.02
  • 200 Day Moving Average: $23.38
  • 52-Week Range: $10.87 - $28.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -18.75
  • P/E Growth: -0.59
  • Market Cap: $1.27B
  • Outstanding Shares: 51,436,000
  • Beta: 1.01
Profitability:
  • Net Margins: -27,686.46%
  • Return on Equity: -56.50%
  • Return on Assets: -53.72%
Debt:
  • Current Ratio: 20.65%
  • Quick Ratio: 20.65%
Additional Links:
Companies Related to Accelerate Diagnostics:

Analyst Ratings

Consensus Ratings for Accelerate Diagnostics (NASDAQ:AXDX) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.33 (2.36% upside)

Analysts' Ratings History for Accelerate Diagnostics (NASDAQ:AXDX)
Show:
DateFirmActionRatingPrice TargetDetails
8/25/2016BTIG ResearchUpgradeNeutral -> BuyView Rating Details
8/9/2016J P Morgan Chase & CoBoost Price TargetOverweight$17.00 -> $25.00View Rating Details
5/16/2016Piper Jaffray CompaniesReiterated RatingOverweight$25.00View Rating Details
1/29/2016William BlairReiterated RatingBuyView Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Accelerate Diagnostics (NASDAQ:AXDX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Accelerate Diagnostics (NASDAQ:AXDX)
Current Year EPS Consensus Estimate: $-1.32 EPS
Next Year EPS Consensus Estimate: $-1.32 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.31)($0.31)($0.31)
Q3 20161($0.32)($0.32)($0.32)
Q4 20161($0.35)($0.35)($0.35)
Q1 20171($0.34)($0.34)($0.34)
Q2 20171($0.34)($0.34)($0.34)
Q3 20171($0.31)($0.31)($0.31)
Q4 20171($0.30)($0.30)($0.30)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Accelerate Diagnostics (NASDAQ:AXDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Accelerate Diagnostics (NASDAQ:AXDX)
Insider Ownership Percentage: 51.40%
Institutional Ownership Percentage: 37.35%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/9/2017Lawrence MehrenInsiderSell400,068$19.00$7,601,292.00View SEC Filing  
1/9/2017Matthew StrobeckDirectorBuy8,000$19.00$152,000.00View SEC Filing  
6/30/2016Jack W SchulerDirectorBuy90,147$13.95$1,257,550.65View SEC Filing  
6/14/2016Jack W SchulerDirectorBuy14,033$13.67$191,831.11View SEC Filing  
6/13/2016Jack W SchulerDirectorBuy15,967$13.70$218,747.90View SEC Filing  
6/10/2016Jack W SchulerDirectorBuy88,316$14.69$1,297,362.04View SEC Filing  
6/9/2016Jack W SchulerDirectorBuy101,272$14.14$1,431,986.08View SEC Filing  
5/20/2016Jack W SchulerDirectorBuy4,270$11.04$47,140.80View SEC Filing  
5/17/2016Jack W SchulerDirectorBuy10,000$11.45$114,500.00View SEC Filing  
5/16/2016Jack W SchulerDirectorBuy11,511$11.91$137,096.01View SEC Filing  
5/13/2016Jack W SchulerDirectorBuy20,000$12.45$249,000.00View SEC Filing  
2/9/2016Jack W SchulerDirectorBuy600,000$11.86$7,116,000.00View SEC Filing  
2/8/2016Jack W SchulerDirectorBuy20,000$12.32$246,400.00View SEC Filing  
2/5/2016Jack W SchulerDirectorBuy7,308$12.65$92,446.20View SEC Filing  
2/4/2016Jack W SchulerDirectorBuy10,000$12.98$129,800.00View SEC Filing  
2/3/2016Jack W SchulerDirectorBuy50,100$13.09$655,809.00View SEC Filing  
2/2/2016Jack W SchulerDirectorBuy20,000$13.46$269,200.00View SEC Filing  
1/21/2016Jack W SchulerDirectorBuy10,000$15.02$150,200.00View SEC Filing  
12/10/2015Larry N FeinbergMajor ShareholderBuy117,647$17.00$1,999,999.00View SEC Filing  
11/5/2015Jack W SchulerDirectorBuy11,899$16.81$200,022.19View SEC Filing  
11/4/2015Jack W SchulerDirectorBuy52,837$16.81$888,189.97View SEC Filing  
10/22/2015Jack W SchulerDirectorBuy2,160$15.82$34,171.20View SEC Filing  
9/29/2015Brink Frank Jm TenDirectorBuy9,800$15.24$149,352.00View SEC Filing  
8/26/2015Jack W SchulerDirectorBuy10,000$17.81$178,100.00View SEC Filing  
8/25/2015Jack W SchulerDirectorBuy10,000$18.56$185,600.00View SEC Filing  
4/17/2015Jack W SchulerDirectorBuy11,000$21.94$241,340.00View SEC Filing  
3/19/2015Matthew StrobeckDirectorBuy2,000$22.04$44,080.00View SEC Filing  
3/9/2015Jack W SchulerDirectorBuy22,584$17.18$387,993.12View SEC Filing  
1/5/2015Jack W SchulerDirectorBuy18,000$18.93$340,740.00View SEC Filing  
9/22/2014Jack W SchulerDirectorBuy2,588$16.44$42,546.72View SEC Filing  
9/19/2014Jack W SchulerDirectorBuy32,411$16.67$540,291.37View SEC Filing  
8/21/2014Jack W SchulerDirectorBuy2,900$16.79$48,691.00View SEC Filing  
8/5/2014Larry N FeinbergMajor ShareholderBuy11,835$15.92$188,413.20View SEC Filing  
8/5/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  
8/4/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  
7/16/2014Larry N FeinbergMajor ShareholderBuy20,000$21.54$430,800.00View SEC Filing  
7/1/2014Jack W SchulerDirectorBuy8,698$25.70$223,538.60View SEC Filing  
6/30/2014Jack W SchulerDirectorBuy10,000$26.09$260,900.00View SEC Filing  
6/30/2014Larry N FeinbergMajor ShareholderBuy20,000$25.72$514,400.00View SEC Filing  
5/12/2014Larry N FeinbergMajor ShareholderBuy297,618$16.80$4,999,982.40View SEC Filing  
2/5/2014Larry N FeinbergMajor ShareholderBuy8,554$24.78$211,968.12View SEC Filing  
1/27/2014Larry N FeinbergMajor ShareholderBuy16,307$13.09$213,458.63View SEC Filing  
12/31/2013Larry N FeinbergMajor ShareholderBuy84,081$12.29$1,033,355.49View SEC Filing  
10/30/2013Larry N FeinbergMajor ShareholderBuy10,000$12.95$129,500.00View SEC Filing  
8/30/2013Larry N FeinbergMajor ShareholderBuy16,001$9.76$156,169.76View SEC Filing  
8/28/2013Larry N FeinbergMajor ShareholderBuy158,445$9.80$1,552,761.00View SEC Filing  
8/16/2013Jack W SchulerDirectorBuy78,494$7.88$618,532.72View SEC Filing  
8/14/2013Jack W SchulerDirectorBuy413,090$8.04$3,321,243.60View SEC Filing  
8/14/2013Larry N FeinbergMajor ShareholderBuy36,814$7.24$266,533.36View SEC Filing  
8/9/2013Larry N FeinbergMajor ShareholderBuy35,168$7.30$256,726.40View SEC Filing  
6/21/2013Larry N FeinbergMajor ShareholderBuy114,250$8.00$914,000.00View SEC Filing  
6/12/2013Larry N FeinbergMajor ShareholderBuy7,175$8.41$60,341.75View SEC Filing  
6/7/2013Larry N FeinbergMajor ShareholderBuy45,508$8.33$379,081.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Accelerate Diagnostics (NASDAQ:AXDX)
DateHeadline
streetinsider.com logoFDA Allows Marketing of Accelerate Diagnostics' (AXDX) Test to Identify Organisms that Cause Bloodstream Infections (NASDAQ:AXDX)
www.streetinsider.com - February 23 at 8:49 PM
feeds.benzinga.com logoAccelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th (NASDAQ:AXDX)
feeds.benzinga.com - February 23 at 4:49 PM
News IconIndicators in Focus on Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - The Standard (NASDAQ:AXDX)
6milestandard.com - February 23 at 3:47 PM
News IconStock Focus: Watching the Levels for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Searcy News (NASDAQ:AXDX)
searcysentinel.com - February 23 at 1:52 AM
News IconAnalysts Watch Accelerate Diagnostics, Inc. (AXDX) And Issue New Targets - NewsDen (NASDAQ:AXDX)
newsden.net - February 21 at 10:27 AM
News IconStock Survey: Viewing Levels for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Davidson Register (NASDAQ:AXDX)
davidsonregister.com - February 14 at 3:15 PM
News IconInside the Numbers for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Davidson Register (NASDAQ:AXDX)
davidsonregister.com - February 14 at 3:15 PM
News IconNumbers in Focus for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Midway Monitor (NASDAQ:AXDX)
midwaymonitor.com - February 14 at 3:15 PM
News IconStock Review for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Searcy News (NASDAQ:AXDX)
searcysentinel.com - February 9 at 8:55 PM
News IconWatching the Levels: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Midway Monitor (NASDAQ:AXDX)
midwaymonitor.com - February 8 at 8:41 PM
News IconTaking Stock: Accelerate in which direction? | News OK - NewsOK.com (NASDAQ:AXDX)
newsok.com - February 5 at 3:45 PM
News IconTechnical Trading: Focus on Shares of Accelerate Diagnostics Inc. (AXDX) - Market Point (NASDAQ:AXDX)
mtptnews.com - January 30 at 4:49 PM
News IconF-Score in Focus for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - The Tribune (NASDAQ:AXDX)
lakecitytribune.com - January 29 at 8:43 PM
News IconUpdate on Valuation Formula's For Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - The Tribune (NASDAQ:AXDX)
lakecitytribune.com - January 29 at 3:43 PM
capitalcube.com logoETFs with exposure to Accelerate Diagnostics, Inc. : January 20, 2017 (NASDAQ:AXDX)
www.capitalcube.com - January 20 at 4:50 PM
nasdaq.com logoCommit To Buy Accelerate Diagnostics At $17.50, Earn 30.4% Annualized Using Options (NASDAQ:AXDX)
www.nasdaq.com - January 19 at 4:54 PM
News IconExperts Analysis on Share Price: Comcast Corporation (NASDAQ:CMCSA) (NASDAQ:AXDX)
thecelebritytruth.com - January 18 at 9:27 PM
News IconMerck & Co., Inc. (NYSE:MRK), Comcast Corporation (NASDAQ:CMCSA) (NASDAQ:AXDX)
larampadinapoli.com - January 18 at 4:26 PM
marketnewsvideo.com logoNotable Wednesday Option Activity: NOW, AXDX, BANC (NASDAQ:AXDX)
www.marketnewsvideo.com - January 18 at 4:26 PM
finance.yahoo.com logoHuge Michael Dell Purchase Highlights Insider Buying: Dell ... - Yahoo Finance (NASDAQ:AXDX)
finance.yahoo.com - January 15 at 8:42 PM
247wallst.com logoHuge Michael Dell Purchase Highlights Insider Buying: Dell Technologies, Accelerate Diagnostics, Loxo Oncology and ... - 24/7 Wall St. (NASDAQ:AXDX)
247wallst.com - January 15 at 3:41 PM
nasdaq.com logoAccelerate Diagnostics Inc (AXDX) PRESIDENT AND CEO Lawrence Mehren Sold $7.6 million of Shares - Nasdaq (NASDAQ:AXDX)
www.nasdaq.com - January 13 at 4:18 PM
capitalcube.com logoAccelerate Diagnostics, Inc. – Value Analysis (NASDAQ:AXDX) : January 12, 2017 (NASDAQ:AXDX)
www.capitalcube.com - January 12 at 3:52 PM
News IconStock Reaching Most Volatile List Today: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Beacon (NASDAQ:AXDX)
wsbeacon.com - January 12 at 2:02 AM
marketexclusive.com logoInsider Trading Activity Accelerate Diagnostics, Inc. (NASDAQ:AXDX) – Director Bought 8,000 shares of Stock (NASDAQ:AXDX)
marketexclusive.com - January 11 at 4:01 PM
capitalcube.com logoAccelerate Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : AXDX-US : January 11, 2017 (NASDAQ:AXDX)
www.capitalcube.com - January 11 at 4:01 PM
finance.yahoo.com logoAccelerate Diagnostics Inc (AXDX) PRESIDENT AND CEO Lawrence Mehren Sold $7.6 million of Shares (NASDAQ:AXDX)
finance.yahoo.com - January 11 at 1:50 AM
capitalcube.com logoETFs with exposure to Accelerate Diagnostics, Inc. : January 9, 2017 (NASDAQ:AXDX)
www.capitalcube.com - January 9 at 4:52 PM
News IconShould You Sell Accelerate Diagnostics, Inc. Based On Current Broker Views? - NewsDen (NASDAQ:AXDX)
newsden.net - January 7 at 10:10 PM
News IconBroker Changes For Accelerate Diagnostics, Inc. (AXDX) - NewsDen (NASDAQ:AXDX)
newsden.net - January 2 at 3:23 PM
nasdaq.com logoAccelerate Diagnostics Becomes Oversold (AXDX) - NASDAQ.com - Nasdaq (NASDAQ:AXDX)
www.nasdaq.com - December 31 at 3:44 PM
nasdaq.com logoAccelerate Diagnostics Becomes Oversold (AXDX) (NASDAQ:AXDX)
www.nasdaq.com - December 30 at 4:02 PM
News IconStock Watch on Shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Beacon (NASDAQ:AXDX)
wsbeacon.com - December 26 at 3:37 PM
investorplace.com logo11 Life Sciences Tools & Services Stocks to Sell Now - Investorplace.com (NASDAQ:AXDX)
investorplace.com - December 22 at 3:47 PM
News IconInvestor Corner: Checking the Numbers for Accelerate Diagnostics ... - Business Daily Leader (NASDAQ:AXDX)
businessdailyleader.com - December 21 at 2:05 AM
News IconShares in Review: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Beacon (NASDAQ:AXDX)
wsbeacon.com - December 20 at 8:12 AM
News IconROIC in Review for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Liberty News (NASDAQ:AXDX)
libertynewsrecord.com - December 17 at 8:50 PM
News IconFollowing the Numbers for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Business Daily Leader (NASDAQ:AXDX)
businessdailyleader.com - December 16 at 3:56 PM
News IconEquity in Focus: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Beacon (NASDAQ:AXDX)
wsbeacon.com - December 15 at 8:37 PM
News IconEV in Focus on Shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Business Daily Leader (NASDAQ:AXDX)
businessdailyleader.com - December 15 at 3:35 PM
News IconF-Score Review on Shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - The Business Journal (NASDAQ:AXDX)
belmontbusinessjournal.com - December 15 at 3:35 PM
finance.yahoo.com logoAccelerate Diagnostics to Present at the 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:AXDX)
finance.yahoo.com - December 14 at 4:28 PM
News IconStock Concentration on Shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Beacon (NASDAQ:AXDX)
wsbeacon.com - December 14 at 1:51 AM
News IconMarket Survey: Checking on Shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Business Daily Leader (NASDAQ:AXDX)
businessdailyleader.com - December 13 at 3:48 PM
News IconStock Watch: FCF Score Check on Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Marion Business Daily (NASDAQ:AXDX)
marionbusinessdaily.com - December 13 at 3:48 PM
News IconCompany Levels in Review: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - OIB News (NASDAQ:AXDX)
oibnews.com - December 9 at 8:49 PM
News IconAccelerate Diagnostics, Inc. (AXDX) Under Analyst Spotlight - UK Market News (NASDAQ:AXDX)
www.ukmarketnews.co.uk - December 9 at 3:47 PM
News IconUpdate on Valuation Formula's For Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Marion Business Daily (NASDAQ:AXDX)
marionbusinessdaily.com - December 9 at 3:47 PM
News IconCompany in Focus: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Beacon (NASDAQ:AXDX)
wsbeacon.com - December 8 at 9:30 PM
News IconSikorsky Opens Testing Facility for Combat Rescue Helicopter (NASDAQ:AXDX)
helihub.com - December 8 at 4:28 PM

Social

What is Accelerate Diagnostics' stock symbol?

Accelerate Diagnostics trades on the NASDAQ under the ticker symbol "AXDX."

Where is Accelerate Diagnostics' stock going? Where will Accelerate Diagnostics' stock price be in 2017?

3 brokerages have issued 12-month target prices for Accelerate Diagnostics' stock. Their predictions range from $25.00 to $26.00. On average, they anticipate Accelerate Diagnostics' share price to reach $25.33 in the next year.

When will Accelerate Diagnostics announce their earnings?

Accelerate Diagnostics is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

Who owns Accelerate Diagnostics stock?

Accelerate Diagnostics' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Birchview Capital LP (4.23%), Arrowpoint Asset Management LLC (1.44%), First Republic Investment Management Inc. (1.44%), Newtyn Management LLC (1.17%), Loomis Sayles & Co. L P (1.05%) and State Street Corp (0.81%). Company insiders that own Accelerate Diagnostics stock include Brink Frank Jm Ten, Jack W Schuler, Larry N Feinberg, Lawrence Mehren and Matthew Strobeck.

Who sold Accelerate Diagnostics stock? Who is selling Accelerate Diagnostics stock?

Accelerate Diagnostics' stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC and Loomis Sayles & Co. L P.

Who bought Accelerate Diagnostics stock? Who is buying Accelerate Diagnostics stock?

Accelerate Diagnostics' stock was purchased by a variety of institutional investors in the last quarter, including Credit Agricole S A, Selkirk Management LLC, Arrowpoint Asset Management LLC, State Street Corp, GSA Capital Partners LLP, Cutter & CO Brokerage Inc., A.R.T. Advisors LLC and AQR Capital Management LLC. Company insiders that have bought Accelerate Diagnostics stock in the last two years include Brink Frank Jm Ten, Jack W Schuler, Larry N Feinberg and Matthew Strobeck.

How do I buy Accelerate Diagnostics stock?

Shares of Accelerate Diagnostics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Accelerate Diagnostics stock cost?

One share of Accelerate Diagnostics stock can currently be purchased for approximately $24.75.

Accelerate Diagnostics (NASDAQ:AXDX) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Accelerate Diagnostics (NASDAQ:AXDX)

Earnings History Chart

Earnings by Quarter for Accelerate Diagnostics (NASDAQ:AXDX)

Dividend History Chart

Dividend Payments by Quarter for Accelerate Diagnostics (NASDAQ:AXDX)

Last Updated on 2/24/2017 by MarketBeat.com Staff